45-year-old D’Et Heffington had just given birth to her son when a friend invited her to take an Oula class in 2016. Oula, as ...

The Montana Highway Patrol reports the crash happened along Montana Highway 93 near mile marker 5 just before 4 p.m., near the community of Evaro. The two people who died at the scene were in a ...

MISSOULA — Keeping up with a resolution to ... Gym members working out at a local gym, VRTX, on Jan. 1 told MTN what has helped them to maintain their fitness goals. Some of these tips include ...

Yes, quite a few restaurants closed in the Missoula area in 2024, including some longtime staple spots that will be sorely missed. But there were also a surprising number of new spots that popped ...

A Missoula couple who says law enforcement wrongly "swatted" their home in 2022 have filed a lawsuit alleging negligence and assault against three local Montana governments. David and Jami ...

Despite high valuation risks, VRTX's innovative CF treatments and diversified pipeline make it a compelling long-term investment opportunity. Vertex stock has lagged the market since then ...

Vertex Pharmaceuticals (VRTX) closed the latest trading day at $402.70, indicating a +0.84% change from the previous session's end. This change outpaced the S&P 500's 0.43% loss on the day.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Arts Missoula will ring in the New Year with dance, music and excitement for local art for the 31st time. MISSOULA — Missoula is already counting down to 2025 creatively with the return of ...

VRTX) concerning possible violations of federal securities laws. On December 19, 2024, the company reported disappointing results from its RewinD-LB Phase 2b clinical trial for the pain drug ...

H.C. Wainwright has recently reiterated Vertex Pharmaceuticals Inc (VRTX) stock to Buy rating, as announced on December 20, 2024, according to Finviz. Earlier, on December 19, 2024, Oppenheimer had ...